Allergy & Asthma Network’s Post

🌸 Happy 1st Day of Spring from the National Medical Association Allergy, Asthma, and Immunology Section! 🌼 Did you know that the changing seasons can have a significant impact on allergies and asthma, especially in the African American community? According to the American Academy of Allergy, Asthma & Immunology (AAAAI), African Americans are more likely to have asthma and often experience more severe symptoms compared to other racial and ethnic groups. Springtime allergens like pollen can trigger asthma attacks and worsen allergy symptoms, making it crucial for individuals to manage their conditions effectively. This season, let's prioritize our respiratory health and raise awareness about the importance of proper allergy and asthma management within the African American community. Together, we can work towards better health outcomes for all. #SpringAllergies #AsthmaAwareness #AllergySeason #HealthEquity #AfricanAmericanHealth #NMAAllergyAsthmaImmunology #Spring2024 #HealthcareForAll [Sources: @AAAAI_org, @NationalMedAssn]

Allergy & Asthma Network is standing strong behind the Elijah E. Cummings Family Asthma Act (H.R. 5749). The bill has been reintroduced in the U.S. House of Representatives. This important legislation would strengthen our public health response to asthma by expanding the CDC's National Asthma Control Program to all 50 states, provide crucial information on asthma through state and local health departments, and ensure support for under-resourced communities. Allergy & Asthma Network joins the American Lung Association, Asthma and Allergy Foundation of America, and other patient advocacy groups in urging support of the Family Asthma Act but we still need your support! lost to this chronic disease. Act now! Your support can change lives.  https://lnkd.in/e3SNNHt8 Here’s 3 ways you can help: 1️⃣Contact your Representatives: Reach out to your local representatives and urge them to support the Elijah E. Cummings Family Asthma Act (H.R. 5749). Your voice matters, and it can make a significant impact! 2️⃣Spread the Word: Share this post and raise awareness about the importance of this bill. The more people know, the stronger our collective voice becomes. 3️⃣Advocate for Change: Join us, alongside organizations like the American Lung Association and the Asthma and Allergy Foundation of America, in advocating for this vital legislation. ➡️Together, we can expand asthma education and awareness nationwide, ensuring that no more lives are lost to this chronic disease. Act now! Your support can change lives.  https://lnkd.in/ez9A_MEm #Advocacy

The disease spectrum involving both Allergic Rhinitis (AR) and Asthma is a well-recognized phenomenon, often referred to as the "united airway disease." Many individuals with asthma also suffer from allergic rhinitis, and vice versa, due to shared underlying inflammatory processes in the respiratory system. The coexistence of these conditions can result in a more severe and challenging clinical course. Allergy Immunotherapy (AIT) emerges as a valuable therapeutic approach for patients with both allergic rhinitis and asthma. Pulmonologists and allergists often collaborate to tailor AIT protocols based on the patient's specific allergens and clinical presentation, recognizing the shared nature of allergic rhinitis and asthma. Join us at RespInsight Scientific Conference - 2024 for invaluable insights into understanding the disease spectrum of allergic rhinitis & asthma and Allergy Immunotherapy (AIT). Attend the conference and hear from the most renowned pulmonologists Dr. Arunesh Kumar and Dr. Ashish Kumar Prakash. The event will be graced by Dr. Anand Jaiswal, Senior Director, Respiratory Allergy Clinic, Respiratory and Sleep Medicine, Medanta The Medicity. 🗓️ Date: 9th and 10th March, 2024 📍 Venue: Four Points by Sheraton, New Delhi #respiratorydisease #conference #medicalconference #healthcare

As we turn the corner out of allergy season, adequate asthma control is next on the agenda as the weather cools. Not only is asthma an independent risk factor for anaphylaxis, it also presents a point of challenge to balance the risk vs benefit of oral steroids in the wake of inadequately controlled asthma as outlined in the brilliant landmark paper by Dr David Price et al in 2018. Price DB, Trudo F, Voorham J, Xu X, Kerkhof M, Ling Zhi Jie J, Tran TN. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018 Aug 29;11:193-204. doi: 10.2147/JAA.S176026. PMID: 30214247; PMCID: PMC6121746.

Exploration of Asthma & Allergy is a multidisciplinary journal that intends to publish papers of the highest quality, significance and innovativeness in all aspects of Asthma & Allergy. Priority is given to work providing innovative and original data or views in the field of molecular and immune mechanisms; molecular, functional and clinical diagnosis, management and treatment of asthma and related disorders. Special Interests will focus on allergic and immunological diseases of Upper Airways, Gastrointestinal Tract, Skin, Eye, Allergen specific ImmunoTherapy, and other disease modifying treatments, etc. Multidisciplinary views concerning Asthma & Allergic diseases diagnosis/management and treatment will be highly considered. Below are some manuscript sections: Welcome to submit your article to our journal through https://lnkd.in/gpUKsNfZ

Exploration of Asthma & Allergy is a multidisciplinary journal that intends to publish papers of the highest quality, significance and innovativeness in all aspects of Asthma & Allergy. Priority is given to work providing innovative and original data or views in the field of molecular and immune mechanisms; molecular, functional and clinical diagnosis, management and treatment of asthma and related disorders. Special Interests will focus on allergic and immunological diseases of Upper Airways, Gastrointestinal Tract, Skin, Eye, Allergen specific ImmunoTherapy, and other disease modifying treatments, etc. Multidisciplinary views concerning Asthma & Allergic diseases diagnosis/management and treatment will be highly considered. Below are some manuscript sections: Welcome to submit your article to our journal through https://lnkd.in/gpUKsNfZ

Allergy & Asthma Network, in conjunction with the American College of Allergy, Asthma and Immunology (ACAAI) annual meeting, invites you to attend the FREE USAsthma Summit in just one week! 🫁 This summit will be held via interactive livestream. It brings together asthma coalitions, state asthma programs, doctors, school nurses, community health workers, patients, advocates and other key stakeholders. What topics will be discussed? View the agenda below: • The State of Asthma in the United States • California Breathing and the Asthma Management Academy (AsMA) Model • How Digital Media Impacts Patient Asthma Care Decisions • EPA National Award Spotlight: Wisconsin Asthma Program • Updates on Asthma Medications and Management • Barriers to Medication Adherence in Asthma: The Importance of Culture and Context • Indoor Air Quality: A Social Determinant of Health • How to Help Patients with Asthma Navigate the Healthcare System • Smoking and Vaping: Impact on Children and Adolescents • GINA 2023 Updates and the Future of Asthma Care • Patient Testimonials We hope to see you online during this FREE virtual summit. Our moderator is Nancy Joseph, DO from the National Medical Association. The USAsthma Summit is timed to coincide with the American College of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting. 🗓Friday, November 10th 📍Registration Available Here: https://lnkd.in/e9qWvAHV #USAsthma2023 #USAsthma

I have been on all sides of a clinical trial. Clinical trials must be a health care option. 1. When I was young - My mom consented for me to be in a clinical trial from age 4 to 17. 2. I wrote a protocol as a new Clinical Researcher. I tried to consent my 1st patient & the patient informed me the protocol was not patient friendly. I learned the importance of Patient Co-Creation of a Clinical Trial Protocol. 3. I have consented as an adult to be a part of a clinical trial. 4. Even though today is Clinical Trials Awareness Day, there are many ways People can engage in research. a. Provide patient and caregiver insights about living with a condition. b. Provide insights about a study protocol and patient participation c. Participate in an disease or condition specific education study. d. Provide insights about new medication options e. Provide expertise to studies f. Help write and review clinical trial summaries for patients. There are many more places patient ans caregiver partners can participate. If you have questions about participating, give me a shout!

Open Access: House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control—A RWE study. Corresponding author: Marek Jutel Read the article here: doi.org/10.1111/all.16052 This study presents 6-year follow-up results for real-world effectiveness of house dust mite (HDM) subcutaneous immunotherapy (SCIT) compared to non-AIT in Germany based on a retrospective claims database analysis. During the follow-up period after at least 2 years of SCIT, the number of prescriptions in the SCIT group reduces by 62.8% for allergic #rhinitis medication and by 42.4% for #asthma medication. Compared to non-AIT, HDM SCIT reduces the probability of asthma onset and the number of patients developing asthma from allergic rhinitis over time. #Allergy_journal Read more articles published in Allergy on allergen #immunotherapy here: https://lnkd.in/dVsjXuR8

🌟 "Clear the Air: Tackling Allergy and Asthma in Our Community" 🌟 May is National Allergy and Asthma Awareness Month, and it's time to focus on the health challenges that disproportionately affect the African American community. Did you know that African Americans are 20% more likely to suffer from asthma compared to the general population? [CDC] Join the NMA Allergy, Asthma and Immunology Section as we dive into prevention, management, and treatment strategies tailored for our community. Let's empower ourselves with knowledge to breathe easier and live better! Let's make this month a turning point for allergy and asthma care! #BreatheEasy #AllergyAwareness #AsthmaAwareness #NMAHealth